Clinical Trial Update: Prophylactic Antimalarial Activity of DB289 in Volunteers [Phase 1, Phase 2]

View source ↗

Summary

This document provides an update on a Phase 1/2 clinical trial evaluating the prophylactic antimalarial activity of DB289 in volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• DB289

Snippet

Sponsor: Immtech Pharmaceuticals, Inc | Conditions: Prophylactic Activity Against Malaria | Phase 1, Phase 2 | Status: COMPLETED